Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 12 | 63153459 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms | 0.030 | 1.000 | 3 | 2011 | 2019 | |||||||
|
1.000 | 12 | 63146696 | 3 prime UTR variant | C/A | snv | 0.12 |
|
Cardiovascular Diseases | 0.030 | 0.667 | 3 | 2011 | 2019 | ||||||||
|
1.000 | 0.040 | 12 | 63150429 | missense variant | A/C;G;T | snv | 0.60; 1.2E-05 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 12 | 63150429 | missense variant | A/C;G;T | snv | 0.60; 1.2E-05 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 12 | 63144678 | 3 prime UTR variant | G/A | snv | 0.29 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 12 | 63144678 | 3 prime UTR variant | G/A | snv | 0.29 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
12 | 63144866 | 3 prime UTR variant | G/A;C;T | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
0.882 | 0.120 | 12 | 63153459 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 12 | 63153459 | intron variant | T/C | snv | 0.26 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.120 | 12 | 63153459 | intron variant | T/C | snv | 0.26 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.120 | 12 | 63153459 | intron variant | T/C | snv | 0.26 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.120 | 12 | 63153459 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||
|
1.000 | 12 | 63146696 | 3 prime UTR variant | C/A | snv | 0.12 |
|
0.010 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
1.000 | 0.040 | 12 | 63153533 | intron variant | A/G | snv | 2.4E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
12 | 63147054 | 3 prime UTR variant | G/A | snv | 0.21 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.925 | 0.040 | 12 | 63154312 | upstream gene variant | T/C | snv | 0.26 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.040 | 12 | 63154312 | upstream gene variant | T/C | snv | 0.26 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.080 | 12 | 63154276 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 12 | 63154276 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 12 | 63154276 | upstream gene variant | C/T | snv | 8.5E-02 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |